Abeona Therapeutics ABEO
Abeona Therapeutics ® Reports Second Quarter 2026 Results and Provides Business Update
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001493152-26-037575
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
- Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
- Ocugen OCGN public float $279M, Jun 30, 2025
- Mersana Therapeutics MRSN
- Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025